Lataa...
Pathology of immune-mediated tissue lesions following treatment with immune checkpoint inhibitors
Immune check point inhibitor (CPI) therapy has revolutionized treatment paradigms for several cancers, but at the cost of triggering a diverse spectrum of immune-mediated injury to non-cancer tissues. The complex biology of these toxicities remains incompletely understood, partly because tissue acqu...
Tallennettuna:
| Julkaisussa: | Rheumatology (Oxford) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900915/ https://ncbi.nlm.nih.gov/pubmed/31816081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez465 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|